GLOB

GLOB

USD

Globant S.A. Common Shares

$62.815+0.795 (1.282%)

即時價格

科技
Information Technology Services
盧森堡

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$62.020

最高

$62.880

最低

$60.675

交易量

1.00M

公司基本面

市值

2.8B

行業

Information Technology Services

國家

Luxembourg

交易統計

平均交易量

1.58M

交易所

NYQ

貨幣

USD

52週範圍

最低 $54.36當前 $62.815最高 $238.32

相關新聞

PR Newswire

Globant to Announce Third Quarter 2025 Financial Results on November 13th

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will...

查看更多
Globant to Announce Third Quarter 2025 Financial Results on November 13th
PR Newswire

Globant to Announce Third Quarter 2025 Financial Results on November 13th

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will...

查看更多
Globant to Announce Third Quarter 2025 Financial Results on November 13th
Analyst Upgrades

Citigroup Initiates Coverage On Globant with Neutral Rating, Announces Price Target of $67

Citigroup analyst Bryan Keane initiates coverage on Globant with a Neutral rating and announces Price Target of $67.

查看更多
Citigroup Initiates Coverage On Globant with Neutral Rating, Announces Price Target of $67
Analyst Upgrades

Wells Fargo Initiates Coverage On Globant with Equal-Weight Rating, Announces Price Target of $61

Wells Fargo analyst Jason Kupferberg initiates coverage on Globant with a Equal-Weight rating and announces Price Target of $61.

查看更多
Wells Fargo Initiates Coverage On Globant with Equal-Weight Rating, Announces Price Target of $61
PR Newswire

MIT Technology Review Insights and Globant Report: Three quarters of global pharma organizations are piloting or deploying agentic AI

Globant (NYSE: GLOB), a digitally native company that helps organizations thrive in a digital and AI-powered future, has partnered with MIT...

查看更多
MIT Technology Review Insights and Globant Report: Three quarters of global pharma organizations are piloting or deploying agentic AI